Brind.

Lazard Asset Management Increases Stake in BlackRock Health Sciences Term Trust

1 report, 1 independent Updated Oct 13
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Lazard Asset Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 64.2% during the first quarter. The firm now owns 621,604 shares, valued at $8,926,000, after purchasing an additional 243,054 shares in the last quarter. During September, short interest in BlackRock Health Sciences Term Trust declined by 60.9%, falling from 83,940 shares on September 15th to 32,798 shares by September 30th.

From tickerreport.com

Why it matters

Some supportBrind's analysis of the reports

The increase in holdings by Lazard Asset Management LLC follows similar buying activity from other large investors, including Saba Capital Management L.P., Corient Private Wealth LP, and Rivernorth Capital Management LLC. This institutional accumulation suggests growing investor confidence in the trust.

From tickerreport.com

Who's involved

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped